Evidence map›Paper›PMID 29063417›Full record

ArticleDigestive diseases and sciences2018

Propofol Does Not Reduce Pyroptosis of Enterocytes and Intestinal Epithelial Injury After Lipopolysaccharide Challenge.

Xu-Yu Zhang, Xi Chen, Hu-Fei Zhang, Su Guan, Shi-Hong Wen, Wen-Qi Huang, Zi-Meng Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. P2YJournal of immunology research · 2026
    Article
  4. Review
  5. Restoration of the Mucosal IgA Response by Improving CD4Digestive diseases and sciences · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. [Role of Bruton's tyrosine kinase in endotoxin/lipopolysaccharide-induced pyroptosis of intestinal cells in scalded mice].Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns · 2021
    Article
  10. Review
  11. Cell death of intestinal epithelial cells in intestinal diseases.Sheng li xue bao : [Acta physiologica Sinica] · 2020
    Review
  12. Frontiers in cellular and infection microbiology · 2020
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xu-Yu ZhangDepartment of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510089, China.
Xi ChenDepartment of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510089, China.
Hu-Fei ZhangDepartment of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510089, China.
Su GuanSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, China.
Shi-Hong WenDepartment of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510089, China.
Wen-Qi HuangDepartment of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510089, China.
Zi-Meng LiuSurgical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-sen University No. 58, Zhongshan 2nd Road, Guangzhou, 510080, China. sumslzm@163.com.ORCID 0000-0002-0161-8051
Sun Yat-sen University · CNSouth China University of Technology · CN

Funding

Natural Science Foundation of Guangdong Province 2014A030313210
6 · The paper itself

Abstract

backgroundTo date, mechanisms of sepsis-induced intestinal epithelial injury are not well known. P2X7 receptor (P2X7R) regulates pyroptosis of lymphocytes, and propofol is usually used for sedation in septic patients.

aimsWe aimed to determine the occurrence of enterocyte pyroptosis mediated by P2X7R and to explore the effects of propofol on pyroptosis and intestinal epithelial injury after lipopolysaccharide (LPS) challenge.

methodsA novel regimen of LPS challenge was applied in vitro and in vivo. Inhibitors of P2X7R (A438079) and NLRP3 inflammasome (MCC950), and different doses of propofol were administered. The caspase-1 expression, caspase-3 expression, caspase-11 expression, P2X7R expression and NLRP3 expression, extracellular ATP concentration and YO-PRO-1 uptake, and cytotoxicity and HMGB1 concentration were detected to evaluate enterocyte pyroptosis in cultured cells and intestinal epithelial tissues. Chiu's score, diamine oxidase and villus length were used to evaluate intestinal epithelial injury. Moreover, survival analysis was performed.

resultsLPS challenge activated caspase-11 expression and P2X7R expression, enhanced ATP concentration and YO-PRO-1 uptake, and led to increased cytotoxicity and HMGB1 concentration. Subsequently, LPS resulted in intestinal epithelial damage, as evidenced by increased levels of Chiu's score and diamine oxidase, and shorter villus length and high mortality of animals. A438079, but not MCC950, significantly relieved LPS-induced enterocyte pyroptosis and intestinal epithelial injury. Importantly, propofol did not confer the protective effects on enterocyte pyroptosis and intestinal epithelia although it markedly decreased P2X7R expression.

conclusionLPS attack leads to activation of caspase-11/P2X7R and pyroptosis of enterocytes. Propofol does not reduce LPS-induced pyroptosis and intestinal epithelial injury, although it inhibits P2X7R upregulation.

Indexed as

AnimalsCell LineEnterocytesHypnotics and SedativesIntestinal MucosaLipopolysaccharidesMaleMiceMice, Inbred C57BLPropofolPyroptosisRatsSpecific Pathogen-Free OrganismsHypnotics and SedativesLipopolysaccharidesPropofolCaspaseEnterocytesLipopolysaccharideP2X7 receptorSepsis

Identifiers

PMID29063417
OpenAlexW2765489847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.